baber/WOPTO huggingface dataset:
Patent CY-1114052-T1 (CY)
Inventor: KONDO SATOSHI
IPC: H04N19/50
Filed: 2013-06-11
Abstract: A motion vector coding unit 117 executes processing including a neighboring block specification step (S100) of specifying a neighboring block which is located in the neighborhood of a current block; a judgment step (Steps S102, S104) of judging whether or not the neighboring block has been coded using a motion vector of another block; a prediction step (S106, S108) of deriving a predictive motion vector of the current block using a motion vector calculated from the motion vector of the other block as a motion vector of the neighboring block; and a coding step (S110) of coding the motion vector of the current block using the predictive motion vector.
Patent CY-1114898-T1 (CY)
Title: Σταθερα σκευασματα πρωτεϊνης
Inventor: DALI MANISHA M
IPC: C07K14/705
Filed: 2014-01-14
Abstract: Η παρούσα εφεύρεση σχετίζεται γενικά με σταθερά σκευάσματα που περιλαμβάνουν CTLA4Ig μόρια, μεταξύ αυτών λυοφιλοποιημένα, και υγρά σκευάσματα για χορήγηση μέσω διαφόρων οδών όπως, για παράδειγμα, μέσω ενδοφλέβιας (IV) και υποδόριας (SC) οδού για την αγωγή παθήσεων του ανοσοποιητικού συστήματος και την επαγωγή ανοχής.
Patent CY-1114804-T1 (CY)
Title: Νεες ενωσεις 951: ενα διφαινυλοξυπροπανοϊκο οξυ ως ρυθμιστης crth2 και ενδιαμεσες ενωσεις
Inventor: BONNERT ROGER VICTOR
IPC: C07D295/18
Filed: 2014-01-15
Abstract: Η παρούσα εφεύρεση αναφέρεται σε ενώσεις αμιδίου χρήσιμες ως φαρμακευτικά προϊόντα για τη θεραπευτική αντιμετώπιση αναπνευστικών διαταραχών όπως του άσθματος, της ρινίτιδας και της COPD.
Patent CY-1118253-T1 (CY)
Title: Υλικο βαθμονομησης για ανοσοποσοτικους προσδιορισμους
Inventor: ROBERTSON JOHN FORSYTH RUSSELL
IPC: G01N33/536
Filed: 2016-11-17
Abstract: Χρήση ενός υλικού βαθμονόμησης, το οποίο περιλαμβάνει σωματικό υγρό θηλαστικών, για τη βαθμονόμηση ενός ανοσοπροσδιορισμού για την ανίχνευση των αυτοαντισωμάτων.
Patent CY-1118707-T1 (CY)
Title: Her2 dna εμβολιο ως συμπληρωματικη αγωγη για καρκινους σε ζωα συντροφιας
Inventor: FISCHER LAURENT BERNARD
IPC: A61K48/00
Filed: 2017-02-08
Abstract: Η αίτηση γνωστοποιεί θεραπευτικά εμβόλια τα οποία βασίζονται στον "pING" DNA πλασμιδικό φορέα ο οποίος εκφράζει το γονίδιο το οποίο κωδικοποιεί την Her2 πρωτεΐνη αρουραίου. Εμβόλια σύμφωνα με την παρούσα γνωστοποίηση χρησιμοποιούνται ως μια συμπληρωματική αγωγή για χειρουργική επέμβαση, ακτινοβολία και/ή χημειοθεραπεία για σκύλους και γάτες με καρκίνους οι οποίοι υπερεκφράζουν το Her2 αντιγόνο, και παρατείνουν το μετεγχειρητικό ελεύθερης νόσου διάστημα και/ή τον χρόνο επιβίωσης. Επίσης περιλαμβάνονται θεραπευτικώς αποτελεσματικές μέθοδοι ανοσοποίησης οι οποίες χρησιμοποιούν τα εν λόγω εμβόλια.
Patent CY-1120778-T1 (CY)
Title: Αναστολεις αντιγραφης ιων γριπης
Inventor: CHARIFSON PAUL S
IPC: A61P31/16
Filed: 2018-10-31
Abstract: Μέθοδοι αναστολής της αντιγραφής ιών γρίπης σε ένα βιολογικό δείγμα ή ασθενή, για τη μείωση της ποσότητας ιών γρίπης σε ένα βιολογικό δείγμα ή ασθενή, και για τη θεραπευτική αγωγή γρίπης σε έναν ασθενή, η οποία περιλαμβάνει χορήγηση στο εν λόγω βιολογικό δείγμα ή ασθενή μιας αποτελεσματικής ποσότητας μιας ένωσης που αντιπροσωπεύεται από τον Δομικό Τύπο (I): Ή ενός φαρμακευτικώς αποδεκτού άλατος αυτής, όπου οι τιμές του Δομικού Τύπου (ΙΑ) είναι όπως περιγράφεται στο παρόν. Μια ένωση αντιπροσωπεύεται από τον Δομικό Τύπο (ΙΑ) ή ένα φαρμακευτικώς αποδεκτό άλας αυτής, όπου οι τιμές του Δομικού Τύπου (ΙΑ) είναι όπως περιγράφεται στο παρόν. Μια φαρμακευτική σύνθεση αποτελείται από μια αποτελεσματική ποσότητα μιας τέτοιας ένωσης ή φαρμακευτικώς αποδεκτού άλατος αυτής, και ενός φαρμακευτικώς αποδεκτού φορέα, ανοσοενισχυτικού ή εκδόχου.
Patent CY-1124837-T1 (CY)
Title: Ενωσεις βενζο[β]θειοφαινιου ως αγωνιστες sting
Inventor: ALTMAN MICHAEL D
IPC: C07D333/60
Filed: 2021-10-22
Abstract: Παρέχονται ενώσεις του γενικού τύπου (la), ενώσεις του γενικού τύπου (la'),ενώσεις του γενικού τύπου (Ib), ενώσεις του γενικού τύπου (Ib'), ενώσεις του γενικού τύπου (Ι), ενώσεις του γενικού τύπου (Ι'), και φαρμακευτικώς αποδεκτά άλατα αυτών, όπου τα R1, R2, R3, R4, R5, R6, R8, R9, Χ1, Χ2, και Χ3 ορίζονται στο παρόν, που μπορεί να είναι χρήσιμες ως διεγέρτες παραγωγής ιντερφερόνης του τύπου Ι, ειδικώς ως δραστικοί παράγοντες STING. Επίσης παρεχόμενες είναι μέθοδοι για τη σύνθεση και χρήση ενώσεων της αποκάλυψης.
Patent GR-900300064-T1 (GR)
Title: Polyurethane foam prepared with reduced levels of hard halocarbon blowing agents
Inventor: SMITS GUIDO FREDDY
IPC: C08L75/04
Filed: 1991-07-31
Abstract: Closed-cell polyisocyanate-based foams are prepared using a blowing agent mixture containing an organic compound having a boiling point in excess of 65 DEG C in conjunction with another organic compound having a boiling point below 40 DEG C. This invention provides for the use of high-boiling blowing agents which previously were not considered suitable for preparing closed-cell foam due to the higher temperatures required to vaporize same and their tendency to condense at ambient temperatures, causing shrinkage of the foam.
Patent GR-930300028-T1 (GR)
Title: Article fabricated from a relatively soft metal plate and cooking vessel comprising such an article
Inventor: FLAMMANG DENIS
IPC: B23K20/00
Filed: 1993-05-24
Abstract: The article is fabricated from a plate (1) made from a relatively soft first metal. It exhibits, on one of its faces, a metal element (2) in the form of a perforated sheet or a grid made from a second metal or alloy which is harder than that of the plate (1), the said metal element (2) being fixed to the said plate by closed-die forging or by beating in order to embed it, at least partially, in the latter. Application especially to cooking vessels. <IMAGE>
Patent HR-P20120626-T1 (HR)
Inventor: GILLES MASSA
IPC: B65D8/12
Filed: 2012-07-31
Abstract: Spremnik  koji sadrži nosivu  platformu (1) koja je izrađena iz krutoga, pravokutnog i dimenzijski stabilnog okvira (2), koja obuhvaća pod (3), te je učvršćena na navedeni pod (3), 4 vezna sustava (4) koji se mogu okretati u ravnini koja je paralelna sa najduljim stranicama okvira  (2) koji su postavljeni na svakom od 4 kuta okvira (2) te su na njega učvršćeni, 4 zglobna kutna stupa (5) koji su u podnožju učvršćeni na svaki od veznih sustava (4), 2 nasuprotna kruta pravokutna dijela (6) koja učvršćuju 4 kutna stupa (5) u parovima po širini platforme (1) tako da  formiraju dvije bočne stjenke, pri čemu svaka stjenka uzrokuje identičnu  rotaciju dva vezna sustava (4) na koje su učvršćene, uobičajene elemente za zaključavanje za dva kuta otvora, koji su definirani sa svakom bočnom stranicom i podom  (3) sa 2 međusobno neovisne vrijednosti, koje iznose 0° i 90°,naznačen time da je opremljen sa dodatnim elementima za zaključavanje za barem jedan od dva kuta otvora za vrijednosti veće od 90° i maksimalno jednake 180°.Patent sadrži još 10 patentnih zahtjeva.
Patent HR-P20150733-T1 (HR)
Title: Tissue protective erythropoietin receptor (nepor) and method of use
Inventor: JACKSON DAVID B
IPC: G01N33/74
Filed: 2015-07-06
Abstract: There is disclosed a molecular composition(s) of a novel tissue protective erythropoietin (EPO) binding receptor protein complex, termed NEPOR. Presence of NEPOR components on a tumour allows EPO to impinge on the survival of associated cells thereby enhancing tumour progression and negatively effecting patient survival. There is disclosed that presence of NEPOR represents a prognostic biomarker for poorer patient outcome. Thus, the method disclosed is for stratifying patients having a tumour as suitable (i.e. NEPOR not present) or non-suitable (i.e., NEPOR present) for EPO treatment, comprising: (a) isolating a tissue sample from an individual who is receiving or is a candidate for receiving erythropoietin, (b) determining the level of expression of the NEPOR gene(s) (mRNA) and/or the presence of the NEPOR gene product (protein) from the isolated tissue, and (c) correlating the presence of an NEPOR gene expression product or the presence of NEPOR protein to a physiological response to the treatment with erythropoietin. Furthermore, by disclosing the molecular compositions of NEPOR species, there are disclosed methods for rationally identifying/designing NEPOR modulating therapeutics. Thus, the present disclosure provides methods for treating neurological insults such as stroke (via enhancement of NEPOR activity) and cancer (via down-regulation of cyto-protective signaling from NEPOR).
Patent SI-1427427-T1 (SI)
Title: Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
Inventor: CASU B
IPC: C08B37/00
Filed: 2001-09-12
Abstract: Totally N-desulphated, N-reacetylated heparin derivatives endowed with antiangiogenic activity and devoid of anticoagulant activity are disclosed.
Patent SI-1553927-T1 (SI)
Title: Gel-stabilized nanoparticulate active agent compositions
Inventor: MCGURK SIMON L
IPC: A61K31/192
Filed: 2003-09-11
Abstract: Disclosed is a solid or semi-solid gelatin nanoparticulate active agent dosage form comprising at least one nanoparticulate active agent and at least one gel forming substance which exhibits gelation sufficient to retain excess water in the solid or semi-solid gelatin form. The active agent particles have an effective average diameter prior to inclusion in the dosage form of less than about 2000 nm. The dosage form of the invention has the advantages of easy administration combined with rapid dissolution of the active agent following administration.
Patent SI-3241550-T1 (SI)
Title: (1r, 2r)-3-(dimenthyl amino-1-ethyl-2-methyl-propyl) phenol for treating painful inflammations
Inventor: SCHIENE KLAUS
IPC: A61P29/00
Filed: 2003-11-18
Abstract: Mixture (X) of at least one analgesic (A) and an inhibitor (B) of cyclo-oxygenase II (COXII). Mixture (X) of at least one analgesic (A) and an inhibitor (B) of cyclo-oxygenase II (COXII), where (A) is a phenyl-substituted tertiary amine of formulae (I)-(III), as racemates, pure or mixed stereoisomers (particularly enantiomers or diastereoisomers), optionally in the form of acids, bases, salts or solvates, preferably hydrates. [Image] X : hydroxy, fluoro, chloro, hydrogen or OCOR 7>; R 1>1-4C linear, branched, saturated or unsaturated alkyl, optionally substituted one or more times, in (I), or 1-4C alkyl, benzyl, trifluoromethyl, hydroxy, benzyloxy. 1-3C alkoxy, chloro or fluoro in (II); R 2> and R 3>hydrogen or 1-4C alkyl (as for R 1>) or together form an optionally substituted 4-7C cycloalkyl; R 9>-R 1> 3>hydrogen, fluoro, chloro, bromo, iodo, (di)fluoromethyl, trifluoromethyl, hydroxy, thiol, OR 1> 4>, trifluoromethoxy, SR 1> 4>, NR 1> 7>R 1> 8>, (trifluoro)methyl- sulfinyl or -sulfonyl, cyano, COOR 1> 4>, nitro, CONR 1> 7>R 1> 8>, 1-6C alkyl (as above) or phenyl, optionally substituted one or more times; R 1> 4>1-6C alkyl, pyridyl, thienyl, thiazolyl, phenyl, benzyl, phenethyl (all optionally substituted one or more times), PO(O-1-4C alkyl)-2, COO1-5C alkyl, CONH(1-3C alkylphenyl), CO(1-5C)alkyl, COCHR 1> 7>-NHR 1> 8>, or CO-phenylene-R 1> 5>; R 1> 5>ortho-OCO(1-3C)alkyl, or meta- or para-CH 2N(R 1> 6>) 2; R 1> 6>1-4C alkyl or morpholino, and all alkyl in R 1> 4>-R 1> 6> are optionally substituted one or more times; R 1> 7> and R 1> 8>hydrogen, 1-6C alkyl (as above), phenyl, benzyl or phenethyl, all optionally substituted one or more times; R 1> 0> with either of R 9> or R 1> together : a OCH 2O, OCH 2CH 2O, OCH=CH, CH=CHO, CH=CMeO, OCMe=CH, (CH 2) 4 or OCH=CHO ring; proviso: in (III), when R 9>, R 1> 1> and R 1> 3> are all hydrogen, one of R 1> 0> and R 1> 2> is hydrogen and the other methoxy, then X is nor hydroxy. ACTIVITY : Analgesic. In the mouse writhing test ( J. Pharmacol. Exp. Ther., 228 (1984) 1) animals were treated with (a) (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol (X); (b) rofecoxib (Y) or (c) a mixture of both at ratio 1:2, then after 30 minutes injected with acetic acid. The ED50 for reduction of writhing was 33 mg/kg for (X) alone and 60.1 mg/kg for (Y) alone, but only 23.3 mg/kg (compare 47 mg/kg for an additive effect) for the mixture. MECHANISM OF ACTION : None given.
Patent SI-1648925-T1 (SI)
Title: Bicyclic peptide imaging agents
Inventor: CUTHBERTSON ALAN
IPC: A61K47/48
Filed: 2004-07-21
Abstract: The invention relates to compounds of formula (I): and their use as targeting vectors that bind to receptors associated with angiogenesis. Such compounds may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's sarcoma.
Patent SI-1911534-T1 (SI)
Title: Joining device with rotating die and punch and method for joining
Inventor: SPREITZER ERICH
IPC: B21D39/00
Filed: 2007-08-28
Abstract: The clinching device (1) for non-positive and/or positive fit clinching of two sheet layers (12), that partially overlap itself to each other, comprises a joining punch (2), a stencil (4), a transport device for accomplishing the sheet layers by an active area of the clinching device between the joining punch and the stencil, and mold punches arranged on the circumferential surface of a roller (3). The stencil is formed by a circumferential surface (9) of conically formed stencil wheels, which is divided into two stencil wheels, which are mirror-symmetrically arranged to an imaginary plane. The clinching device (1) for non-positive and/or positive fit clinching of two sheet layers (12), that partially overlap itself to each other, comprises a joining punch (2), a stencil (4), a transport device for accomplishing the sheet layers by an active area of the clinching device between the joining punch and the stencil, and mold punches arranged on the circumferential surface of a roller (3). The stencil is formed by a circumferential surface (9) of conically formed stencil wheels, which is divided into two stencil wheels, which are mirror-symmetrically arranged to an imaginary plane. The joining punch is revolvably arranged around a first rotational axis and the stencil is revolvably arranged around a second rotational axis. The first and the second rotational axis are arranged in the active area spaced from each other and diagonal to the transport direction. The imaginary plane lies in transport direction of the sheet layers and vertical to the first rotational axis. The joining punch is formed at the outer circumferential of a joining wheels. Each stencil wheels has a self rotational axis, namely a second and a third rotational axis, and both rotational axis lies in the same plane to each other at an angle of 160[deg] . The stencil comprises revolving shoulders arranged on the circumferential surface of the stencil wheels. The shoulders form flanks of the stencil. The flanks of the stencils form an undercut. The angle of the lateral flanks for the plane of the accomplished sheet layers is 84[deg] . The stencil wheels are embedded in each case by a spherical roller bearing on a common shaft that is aligned parallel to the first rotational axis. The mold punches lie in a rotational plane of the roller, have same distance to each other in circumferential direction, and have a convex upper side at its free end and flanks that converge on the free end of the mold punches. The lateral flanks are arranged diagonal/parallel to the transport direction at an angle of 45[deg] to the surface of the roller. The roller has lateral defining flanges for lateral guiding of the stencils. Independent claims are included for procedure for non-positive and/or positive fit clinching connection.
Patent SI-2268137-T1 (SI)
Title: Pesticidal aqueous suspension composition
Inventor: ISHIHARA YOSHIAKI
IPC: A01P3/00
Filed: 2009-03-31
Abstract: When an organosilicone surface active agent is added to a pesticidal aqueous suspension composition containing an active ingredient compound of a sparingly water-soluble pesticide for the purpose of attaining activity enhancement and formulation, the following problems arise: such that (1) the viscosity of the composition increases; (2) a large amount of foams due to the organosilicone surface active agent tends to generate at the time of preparation of a spray solution; and the like. Thus, measuring the composition and preparation of a spray solution were difficult. The present invention provides a pesticidal aqueous suspension composition including (a) an active ingredient compound of a sparingly water-soluble pesticide, (b) an organosilicone surface active agent, (c) a viscosity-reducing agent, (d) an antifoaming agent, (e) a pH adjustor and (f) a dispersant, which is suppressed in increasing in the viscosity, is easy to measure, hardly generates foams at the time of dilution with water and is easy to prepare a spray solution.
Patent DE-3587949-T2 (DE)
Inventor: VAUGHAN JOHN
IPC: C07K16/00
Filed: 1985-08-02
Granted: 1995-07-06
Abstract: Antigens, immunogens, inocula, antibodies, diagnostic methods and systems relating to Epstein-Barr virus nuclear antigen (EBNA) are disclosed. Each of the compounds, compositions, methods or systems contains a synthetic, random copolymer polypeptide having about 6 to about 40 residues, or an antibody containing site that immunoreacts with such a polypeptide. The polypeptide includes the five amino acid residue sequence -Gly-R1-Gly-R2-Gly-, wherein R1 and R2 are the same or different amino acid residues selected from the group consisting of Ala, Asn, Arg, Gly, Leu, Pro, Ser, and Thr, with the provision that R1 and R2 are not both Gly. The polypeptide contains at least 25 mole percent Gly residues, and when linked to a carrier and introduced in an effective amount into a mammalian host is capable of inducing production of antibodies that immunoreact with EBNA.
Patent DE-3687223-T2 (DE)
Inventor: BROWN COLSTOUN DE
IPC: G01S7/481
Filed: 1986-12-31
Granted: 1993-05-13
Abstract: The station's optical transmitting and receiving equipment is incorporated in a single system. In the direction of transmission, the system comprises a device (3) for separating the transmitted and back- scattered beams, an optical component (5) for converting the small diameter parallel transmitted beam into a divergent beam, and a telescope (6) adapted to converge the divergent beam received from the optical component into a parallel beam of larger diameter. The back- scattered beam covers this path in the opposite direction to that of the transmitted beam. 
<??>Application to the detection of smoke from fires, particularly forest fires. 
<IMAGE>
Patent DE-3885684-T2 (DE)
Inventor: JENSON PER
IPC: B29C61/06
Filed: 1988-09-08
Granted: 1994-06-23
Abstract: A heat recoverable conductive polymeric tubular article shrinks radially when electrical current is passed therethrough. It is powered by elongate electrodes extending along the article along part of the length only of the article, thereby defining an inwardly directed electrode end material of the article preferably has specific electrical properties to compensate for the increased current density that would otherwise exist at the inwardly directed electrode end, and which could lead to burning or hot spot formation.
Patent DE-3886841-T2 (DE)
Inventor: WARSZAWSKI BERNARD
IPC: G02F1/15
Filed: 1988-07-22
Granted: 1994-07-28
Abstract: A process for manufacturing a light-modulating device comprising picture element, the process comprising steps of applying (by means of the "thick film" techniques such as silk-screen techniques) a layer of electrolytic material, and then applying a layer of counter-electrode material divided into portions of a layer defined and distributed according to a surface pattern coordinated with a surface pattern of transparent electrodes.
Patent TR-199801263-T2 (TR)
Inventor: TIMMERS FRANCIS J
IPC: C07F17/00
Filed: 1996-12-05
Abstract: BIr konjuge dien ligand grubu ihtiva eden ve dienin geçis metaline ya bir sigma-kompleksi veya bir pi-kompleksi seklinde bagli oldugu bisiklopentadienil Grup 4 geçis metali kompleksleri, herhangi bir siraya göre: a)M'X3 veya M"X4 formülüne takabül bir Grup 4 metal tuzunu veya bunun bir Lewis bazi katilma ürününü, b) bir konjuge dieni,D', c) bir indirgeyici maddeyi ve d) CpM* veya (Cp-Cp)M*n formülüne sahip bir bilesigi reaksiyona sokmak suretiyle kolaylikla hazirlanirlar; burada M',+3 formal oksidasyon durumunda titan, zirkon veya hafniyumdur; M", +4 formal oksidasyon durumunda titan, zirkon veya hafniyumdur; X, bir halojenür, C1-6 hidrokarbiloksi veya di(C1-6 hidrokarbil) amido grubudur.
Patent TR-199900153-T2 (TR)
Inventor: DHINGRA URVASHI HOODA
IPC: A61K31/404
Filed: 1997-07-19
Abstract: R'nin alkil, alkiltio veya hidrosi oldugu formül (I)'e ait bilesikler ve ayni zamanda formül (I)'e ait bilesiklerin farmasötik açidan kabul gören tuzlari, kanser tedavisi için yararli çogalma önleyici maddelerdir.
Patent DE-60002085-T2 (DE)
Inventor: CHANET JEAN-PIERRE
IPC: A01K11/00
Filed: 2000-07-07
Granted: 2004-03-04
Abstract: The present invention provides a device for tattooing animals, the device comprising a moving needle-carrier plate (4) whose needles (41) are designed to be covered in ink and to press, at the end of the stroke of the plate, against the skin (P) of an animal in order to tattoo it, and a spongy pad (6) soaked in ink lying on the path of the needles (41) and suitable for being pierced by the needles so that they project against the skin (P) of the animal at the moment of impact. It is remarkable in that said pad (6) is integrated with the plate (4), the assembly being moved by a hammer (8) housed in a guide barrel (5), and that said plate (4) is secured to the outside face (92) of a resilient diaphragm (9) which closes one end of said barrel (5).
Patent DE-60002516-T2 (DE)
Inventor: MERINO LOPEZ JOSE
IPC: B29C33/02
Filed: 2000-02-28
Granted: 2004-03-18
Abstract: Straight molding strips (16) slide in slots of a spiral molding strip (12, 14), forming openings (19) when fully-inserted. The openings mold rubber bridging sections. The straight strips can be fully retracted for extraction from the molding, and are subsequently re-inserted to make the next molding. The complete molding section of the assembly, resembles a cylindrical inverted basket curved about an axis (XX'). The straight strips are held by a carrier (15) which slides along the guide (17).  Preferred features: To take the spiral out of the molding, the straight strips are first pulled out, then the spiral is turned about the axis, unscrewing it from the molding. For this, the helical part can be both rotated about, and translated along, the XX' axis. The straight strips are connected to a return spring, urging re-insertion, when re-forming the molding assembly. A mold carrying one or more such assemblies is also claimed.
Patent DE-60002921-T2 (DE)
Inventor: GUENEBAUD PHILIPPE
IPC: H04N21/4367
Filed: 2000-12-19
Granted: 2004-03-11
Abstract: The present invention relates to an interface module for a host ( 2 ) such as a digital television decoder, permitting the processing of information coming from the host ( 2 ) in a conditioned manner subject to a conditional access system ( 11 ), comprising authorization means ( 7 ) by which the user justifies his access rights. The module has at least one means ( 8 ) for identifying the authorization means ( 7 ); means ( 10 ) for storing a plurality of conditional access systems ( 11 ), processing means ( 9 ) adapted to process the information coming from the host ( 2 ) utilizing the conditional access system ( 11 ) corresponding to the authorization means ( 7 ) identified by the identification means ( 8 ), permitting to exploit a plurality of conditional access systems ( 11 ) within the same module The invention also relates to a decoder and a method adapted to be performed by the interface module For use in digital television decoders
Patent DE-60005532-T2 (DE)
Inventor: STUEMPERT MARTIN
IPC: H04L12/56
Filed: 2000-07-19
Granted: 2004-08-05
Abstract: The invention herein relates to implementation of basic call setup for GSM/UMTS core networks, including supplementary services CFU, CFB, CFNREA, CFNRY, CW, HOLD and MPTY, with transporting Media Gateway address and logical point coding and framing information in a forward direction in cellular networks with separation of call control and bearer control. Call setup is described in various traffic cases.